Inhibitors of histone deacetylases in cl
✍
M.D. Cantley; D.P. Fairlie; P.M. Bartold; K.D. Rainsford; G.T. Le; A.J. Lucke; C
📂
Article
📅
2011
🏛
John Wiley and Sons
🌐
English
⚖ 424 KB
Histone deacetylase inhibitors (HDACi) suppress cancer cell growth, inflammation, and bone resorption. The aim of this study was to determine the effect of inhibitors of different HDAC classes on human osteoclast activity in vitro. Human osteoclasts generated from blood mononuclear cells stimulated